Advertisement

Virologica Sinica

, Volume 28, Issue 1, pp 3–15 | Cite as

An overview of the highly pathogenic H5N1 influenza virus

  • Jingchuan Yin
  • Shi Liu
  • Ying ZhuEmail author
Review

Abstract

Since the first human case of H5N1 avian influenza virus infection was reported in 1997, this highly pathogenic virus has infected hundreds of people around the world and resulted in many deaths. The ability of H5N1 to cross species boundaries, and the presence of polymorphisms that enhance virulence, present challenges to developing clear strategies to prevent the pandemic spread of this highly pathogenic avian influenza (HPAI) virus. This review summarizes the current understanding of, and recent research on, the avian influenza H5N1 virus, including transmission, virulence, pathogenesis, clinical characteristics, treatment and prevention.

Keywords

Avian influenza H5N1 Transmission Virulence Pathogenesis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abdelwhab E M and Hafez H M. 2011. An overview of the epidemic of highly pathogenic H5N1 avian influenza virus in Egypt: epidemiology and control challenges. Epidemiol Infect, 139: 647–657.PubMedCrossRefGoogle Scholar
  2. Ayora-Talavera G, Shelton H, Scull M A, Ren J, Jones I M, Pickles R J and Barclay W S. 2009. Mutations in H5N1 influenza virus hemagglutinin that confer binding to human tracheal airway epithelium. PLoS One, 4: e7836.PubMedCrossRefGoogle Scholar
  3. Baskin C R, Bielefeldt-Ohmann H, Tumpey T M, Sabourin P J, Long J P, Garcia-Sastre A, Tolnay A E, Albrecht R, Pyles J A, Olson P H, Aicher L D, Rosenzweig E R, Murali-Krishna K, Clark E A, Kotur M S, Fornek J L, Proll S, Palermo R E, Sabourin C L and Katze M G. 2009. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc Natl Acad Sci U S A, 106: 3455–3460.PubMedCrossRefGoogle Scholar
  4. Beigel J H, Farrar J, Han A M, Hayden F G, Hyer R, de Jong M D, Lochindarat S, Nguyen T K, Nguyen T H, Tran T H, Nicoll A, Touch S, Yuen K Y and Writing Committee of the World Health Organization Consultation on Human Influenza A H. 2005. Avian influenza A (H5N1) infection in humans. N Engl J Med, 353: 1374–1385.PubMedCrossRefGoogle Scholar
  5. Bel M, Ocana-Macchi M, Liniger M, McCullough K C, Matrosovich M and Summerfield A. 2011. Efficient sensing of avian influenza viruses by porcine plasmacytoid dendritic cells. Viruses, 3: 312–330.PubMedCrossRefGoogle Scholar
  6. Bissel S J, Giles B M, Wang G, Olevian D C, Ross T M and Wiley C A. 2012. Acute murine H5N1 influenza A encephalitis. Brain Pathol, 22: 150–158.PubMedCrossRefGoogle Scholar
  7. Budimir N, Huckriede A, Meijerhof T, Boon L, Gostick E, Price D A, Wilschut J and de Haan A. 2012. Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity. PLoS One, 7: e30898.PubMedCrossRefGoogle Scholar
  8. Cameron M J, Ran L, Xu L, Danesh A, Bermejo-Martin J F, Cameron C M, Muller M P, Gold W L, Richardson S E, Poutanen S M, Willey B M, DeVries M E, Fang Y, Seneviratne C, Bosinger S E, Persad D, Wilkinson P, Greller L D, Somogyi R, Humar A, Keshavjee S, Louie M, Loeb M B, Brunton J, McGeer A J, Canadian S R N and Kelvin D J. 2007. Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome. J Virol, 81: 8692–8706.PubMedCrossRefGoogle Scholar
  9. Cattoli G, Monne I, Fusaro A, Joannis T M, Lombin L H, Aly M M, Arafa A S, Sturm-Ramirez K M, Couacy-Hymann E, Awuni J A, Batawui K B, Awoume K A, Aplogan G L, Sow A, Ngangnou A C, El Nasri Hamza I M, Gamatie D, Dauphin G, Domenech J M and Capua I. 2009. Highly pathogenic avian influenza virus subtype H5N1 in Africa: a comprehensive phylogenetic analysis and molecular characterization of isolates. PLoS One, 4: e4842.PubMedCrossRefGoogle Scholar
  10. Cauthen A N, Swayne D E, Schultz-Cherry S, Perdue M L and Suarez D L. 2000. Continued circulation in China of highly pathogenic avian influenza viruses encoding the hemagglutinin gene associated with the 1997 H5N1 outbreak in poultry and humans. J Virol, 74.Google Scholar
  11. Centers for Disease Control and Prevention. 1997. Isolation of avian influenza A(H5N1) viruses from humans—Hong Kong, May–December 1997. MMWR Morb Mortal Wkly Rep, 46: 1204–1207.Google Scholar
  12. Chan M C, Cheung C Y, Chui W H, Tsao S W, Nicholls J M, Chan Y O, Chan R W, Long H T, Poon L L, Guan Y and Peiris J S. 2005. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res, 6: 135.PubMedCrossRefGoogle Scholar
  13. Chan R W, Yuen K M, Yu W C, Ho C C, Nicholls J M, Peiris J S and Chan M C. 2010. Influenza H5N1 and H1N1 virus replication and innate immune responses in bronchial epithelial cells are influenced by the state of differentiation. PLoS One, 5: e8713.PubMedCrossRefGoogle Scholar
  14. Chan R W, Chan M C, Wong A C, Karamanska R, Dell A, Haslam S M, Sihoe A D, Chui W H, Triana-Baltzer G, Li Q, Peiris J S, Fang F and Nicholls J M. 2009. DAS181 inhibits H5N1 influenza virus infection of human lung tissues. Antimicrob Agents Chemother, 53: 3935–3941.PubMedCrossRefGoogle Scholar
  15. Chantratita W, Sukasem C, Kaewpongsri S, Srichunrusami C, Pairoj W, Thitithanyanont A, Chaichoune K, Ratanakron P, Songserm T, Damrongwatanapokin S and Landt O. 2008. Qualitative detection of avian influenza A (H5N1) viruses: a comparative evaluation of four real-time nucleic acid amplification methods. Mol Cell Probes, 22: 287–293.PubMedCrossRefGoogle Scholar
  16. Chen W, Calvo P A, Malide D, Gibbs J, Schubert U, Bacik I, Basta S, O’Neill R, Schickli J, Palese P, Henklein P, Bennink J R and Yewdell J W. 2001. A novel influenza A virus mitochondrial protein that induces cell death. Nat Med, 7: 1306–1312.PubMedCrossRefGoogle Scholar
  17. Cheung C L, Rayner J M, Smith G J, Wang P, Naipospos T S, Zhang J, Yuen K Y, Webster R G, Peiris J S, Guan Y and Chen H. 2006. Distribution of amantadine-resistant H5N1 avian influenza variants in Asia. J Infect Dis, 193: 1626–1629.PubMedCrossRefGoogle Scholar
  18. Chutinimitkul S, van Riel D, Munster V J, van den Brand J M, Rimmelzwaan G F, Kuiken T, Osterhaus A D, Fouchier R A and de Wit E. 2010. In vitro assessment of attachment pattern and replication efficiency of H5N1 influenza A viruses with altered receptor specificity. J Virol, 84: 6825–6833.PubMedCrossRefGoogle Scholar
  19. Clementi N, De Marco D, Mancini N, Solforosi L, Moreno G J, Gubareva L V, Mishin V, Di Pietro A, Vicenzi E, Siccardi A G, Clementi M and Burioni R. 2011. A human monoclonal antibody with neutralizing activity against highly divergent influenza subtypes. PLoS One, 6: e28001.PubMedCrossRefGoogle Scholar
  20. Conenello G M, Tisoncik J R, Rosenzweig E, Varga Z T, Palese P and Katze M G. 2011. A single N66S mutation in the PB1-F2 protein of influenza A virus increases virulence by inhibiting the early interferon response in vivo. J Virol, 85: 652–662.PubMedCrossRefGoogle Scholar
  21. Couch R B. 2000. Prevention and treatment of influenza. N Engl J Med, 343: 1778–1787.PubMedCrossRefGoogle Scholar
  22. Das A, Spackman E, Senne D, Pedersen J and Suarez D L. 2006. Development of an internal positive control for rapid diagnosis of avian influenza virus infections by real-time reverse transcription-PCR with lyophilized reagents. J Clin Microbiol, 44: 3065–3073.PubMedCrossRefGoogle Scholar
  23. de Jong M D and Hien T T. 2006. Avian influenza A (H5N1). J Clin Virol, 35: 2–13.PubMedCrossRefGoogle Scholar
  24. de Jong M D Bach V C, Phan T Q, Vo M H, Tran T T, Nguyen B H, Beld M, Le T P, Truong H K, Nguyen V V, Tran T H, Do Q H and Farrar J. 2005. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med, 352: 686–691.PubMedCrossRefGoogle Scholar
  25. de Jong M D, Tran T T, Truong H K, Vo M H, Smith G J, Nguyen V C, Bach V C, Phan T Q, Do Q H, Guan Y, Peiris J S, Tran T H and Farrar J. 2005. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med, 353: 2667–2672.PubMedCrossRefGoogle Scholar
  26. de Jong M D, Simmons C P, Thanh T T, Hien V M, Smith G J, Chau T N, Hoang D M, Chau N V, Khanh T H, Dong V C, Qui P T, Cam B V, Ha do Q, Guan Y, Peiris J S, Chinh N T, Hien T T and Farrar J. 2006. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med, 12: 1203–1207.PubMedCrossRefGoogle Scholar
  27. Ding N, Chen Q, Zhang W, Ren S, Guo Y and Li Y. 2012. Structure-activity relationships of saponin derivatives: A series of entry inhibitors for highly pathogenic H5N1 influenza virus. Eur J Med Chem, 53C: 316–326.CrossRefGoogle Scholar
  28. Du N, Zhou J, Lin X, Zhang Y, Yang X, Wang Y and Shu Y. 2010. Differential activation of NK cells by influenza A pseudotype H5N1 and 1918 and 2009 pandemic H1N1 viruses. J Virol, 84: 7822–7831.PubMedCrossRefGoogle Scholar
  29. Du Q S, Wang S Q and Chou K C. 2007. Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus. Biochem Biophys Res Commun, 362: 525–531.PubMedCrossRefGoogle Scholar
  30. Duan L, Bahl J, Smith G J, Wang J, Vijaykrishna D, Zhang L J, Zhang J X, Li K S, Fan X H, Cheung C L, Huang K, Poon L L, Shortridge K F, Webster R G, Peiris J S, Chen H and Guan Y. 2008. The development and genetic diversity of H5N1 influenza virus in China, 1996–2006. Virology, 380: 243–254.PubMedCrossRefGoogle Scholar
  31. Fall I, Sanou A, Ngom G, Dieng M, Sankale A A and Ndoye M. 2006. Strangulated umbilical hernias in children. Pediatr Surg Int, 22: 233–235.PubMedCrossRefGoogle Scholar
  32. Fang J, Hao Q, Liu L, Li Y, Wu J, Huo X and Zhu Y. 2011. Epigenetic Changes Mediated by MicroRNA miR29 Activate Cyclooxygenase 2 and Lambda-1 Interferon Production during Viral Infection. J Virol, 86: 1010–1020.PubMedCrossRefGoogle Scholar
  33. Gabriel G, Dauber B, Wolff T, Planz O, Klenk H D and Stech J. 2005. The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. Proc Natl Acad Sci U S A, 102: 18590–18595.PubMedCrossRefGoogle Scholar
  34. Gambaryan A S, Tuzikov A B, Pazynina G V, Desheva J A, Bovin N V, Matrosovich M N and Klimov A I. 2008. 6-sulfo sialyl Lewis X is the common receptor determinant recognized by H5, H6, H7 and H9 influenza viruses of terrestrial poultry. Virol J, 5: 85.PubMedCrossRefGoogle Scholar
  35. Gao P, Watanabe S, Ito T, Goto H, Wells K, McGregor M, Cooley A J and Kawaoka Y. 1999. Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong. J Virol, 73: 3184–3189.PubMedGoogle Scholar
  36. Gao Y, Zhang Y, Shinya K, Deng G, Jiang Y, Li Z, Guan Y, Tian G, Li Y, Shi J, Liu L, Zeng X, Bu Z, Xia X, Kawaoka Y and Chen H. 2009. Identification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian host. PLoS Pathog, 5: e1000709PubMedCrossRefGoogle Scholar
  37. Gill J R, Sheng Z M, Ely S F, Guinee D G, Beasley M B, Suh J, Deshpande C, Mollura D J, Morens D M, Bray M, Travis W D and Taubenberger J K. 2010. Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch Pathol Lab Med, 134: 235–243.PubMedGoogle Scholar
  38. Guan Y, Shortridge K F, Krauss S and Webster R G. 1999. Molecular characterization of H9N2 influenza viruses: were they the donors of the “internal” genes of H5N1 viruses in Hong Kong? Proc Natl Acad Sci U S A, 96: 9363–9367.PubMedCrossRefGoogle Scholar
  39. Guan Y, Peiris J S, Lipatov A S, Ellis T M, Dyrting K C, Krauss S, Zhang L J, Webster R G and Shortridge K F. 2002. Emergence of multiple genotypes of H5N1 avian influenza viruses in Hong Kong SAR. Proc Natl Acad Sci U S A, 99: 8950–8955.PubMedCrossRefGoogle Scholar
  40. Gutierrez R A, Sorn S, Nicholls J M and Buchy P. 2011. Eurasian Tree Sparrows, risk for H5N1 virus spread and human contamination through Buddhist ritual: an experimental approach. PLoS One, 6: e28609.PubMedCrossRefGoogle Scholar
  41. Hale B G, Kerry P S, Jackson D, Precious B L, Gray A, Killip M J, Randall R E and Russell R J. 2010. Structural insights into phosphoinositide 3-kinase activation by the influenza A virus NS1 protein. Proc Natl Acad Sci U S A, 107: 1954–1959.PubMedCrossRefGoogle Scholar
  42. Harvey R, Wheeler J X, Wallis C L, Robertson J S and Engelhardt O G. 2008. Quantitation of haemagglutinin in H5N1 influenza viruses reveals low haemagglutinin content of vaccine virus NIBRG-14 (H5N1). Vaccine, 26: 6550–6554.PubMedCrossRefGoogle Scholar
  43. Haye K, Burmakina S, Moran T, Garcia-Sastre A and Fernandez-Sesma A. 2009. The NS1 protein of a human influenza virus inhibits type I interferon production and the induction of antiviral responses in primary human dendritic and respiratory epithelial cells. J Virol, 83: 6849–6862.PubMedCrossRefGoogle Scholar
  44. Hoelscher M A, Garg S, Bangari D S, Belser J A, Lu X, Stephenson I, Bright R A, Katz J M, Mittal S K and Sambhara S. 2006. Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice. Lancet, 367: 475–481.PubMedCrossRefGoogle Scholar
  45. Hoffmann E, Stech J, Leneva I, Krauss S, Scholtissek C, Chin P S, Peiris M, Shortridge K F and Webster R G. 2000. Characterization of the influenza A virus gene pool in avian species in southern China: was H6N1 a derivative or a precursor of H5N1? J Virol, 74: 6309–6315.PubMedCrossRefGoogle Scholar
  46. Hsieh S M and Chang S C. 2006. Insufficient perforin expression in CD8+ T cells in response to hemagglutinin from avian influenza (H5N1) virus. J Immunol, 176: 4530–4533.PubMedGoogle Scholar
  47. Hui D S. 2008. Review of clinical symptoms and spectrum in humans with influenza A/H5N1 infection. Respirology, 13Suppl 1: S10–13.PubMedCrossRefGoogle Scholar
  48. Imai H, Shinya K, Takano R, Kiso M, Muramoto Y, Sakabe S, Murakami S, Ito M, Yamada S, Le M T, Nidom C A, Sakai-Tagawa Y, Takahashi K, Omori Y, Noda T, Shimojima M, Kakugawa S, Goto H, Iwatsuki-Horimoto K, Horimoto T and Kawaoka Y. 2010. The HA and NS genes of human H5N1 influenza A virus contribute to high virulence in ferrets. PLoS Pathog, 6: e1001106.PubMedCrossRefGoogle Scholar
  49. Ito T, Couceiro J N, Kelm S, Baum L G, Krauss S, Castrucci M R, Donatelli I, Kida H, Paulson J C, Webster R G and Kawaoka Y. 1998. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol, 72: 7367–7373.PubMedGoogle Scholar
  50. Jackson D, Hossain M J, Hickman D, Perez D R and Lamb R A. 2008. A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity. Proc Natl Acad Sci U S A, 105: 4381–4386.PubMedCrossRefGoogle Scholar
  51. Jang H, Boltz D, Sturm-Ramirez K, Shepherd K R, Jiao Y, Webster R and Smeyne R J. 2009. Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration. Proc Natl Acad Sci U S A, 106: 14063–14068.PubMedCrossRefGoogle Scholar
  52. Jia D, Rahbar R, Chan R W, Lee S M, Chan M C, Wang B X, Baker D P, Sun B, Peiris J S, Nicholls J M and Fish E N. 2010. Influenza virus non-structural protein 1 (NS1) disrupts interferon signaling. PLoS One, 5: e13927.PubMedCrossRefGoogle Scholar
  53. Kandun I N, Tresnaningsih E, Purba W H, Lee V, Samaan G, Harun S, Soni E, Septiawati C, Setiawati T, Sariwati E and Wandra T. 2008. Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case series. Lancet, 372: 744–749.PubMedCrossRefGoogle Scholar
  54. Kimble B, Nieto G R and Perez D R. 2010. Characterization of influenza virus sialic acid receptors in minor poultry species. Virol J, 7: 365.PubMedCrossRefGoogle Scholar
  55. Kongchanagul A, Suptawiwat O, Boonarkart C, Kitphati R, Puthavathana P, Uiprasertkul M and Auewarakul P. 2011. Decreased expression of surfactant protein D mRNA in human lungs in fatal cases of H5N1 avian influenza. J Med Virol, 83: 1410–1417.PubMedCrossRefGoogle Scholar
  56. Kuiken T, van den Brand J, van Riel D, Pantin-Jackwood M and Swayne D E. 2010. Comparative pathology of select agent influenza a virus infections. Vet Pathol, 47: 893–914.PubMedCrossRefGoogle Scholar
  57. Le Q M, Kiso M, Someya K, Sakai Y T, Nguyen T H, Nguyen K H, Pham N D, Ngyen H H, Yamada S, Muramoto Y, Horimoto T, Takada A, Goto H, Suzuki T, Suzuki Y and Kawaoka Y. 2005. Avian flu: isolation of drug-resistant H5N1 virus. Nature, 437: 1108.PubMedCrossRefGoogle Scholar
  58. Lee D C, Cheung C Y, Law A H, Mok C K, Peiris M and Lau A S. 2005. p38 mitogen-activated protein kinase-dependent hyperinduction of tumor necrosis factor alpha expression in response to avian influenza virus H5N1. J Virol, 79: 10147–10154.PubMedCrossRefGoogle Scholar
  59. Lee D C, Law A H, Hui K, Tam A H, Peiris J S and Lau A S. 2012. Interferon dysregulation and virus-induced cell death in avian influenza H5N1 virus infections. Hong Kong Med J, 18 Suppl 2: 12–16.Google Scholar
  60. Lee S M, Gardy J L, Cheung C Y, Cheung T K, Hui K P, Ip N Y, Guan Y Hancock R E and Peiris J S. 2009. Systems-level comparison of host-responses elicited by avian H5N1 and seasonal H1N1 influenza viruses in primary human macrophages. PLoS One, 4: e8072.PubMedCrossRefGoogle Scholar
  61. Lei F and Shi W. 2011. Prospective of Genomics in Revealing Transmission, Reassortment and Evolution of Wildlife-Borne Avian Influenza A (H5N1) Viruses. Curr Genomics, 12: 466–474.PubMedCrossRefGoogle Scholar
  62. Li C, Hatta M, Nidom C A, Muramoto Y, Watanabe S, Neumann G and Kawaoka Y. 2010. Reassortment between avian H5N1 and human H3N2 influenza viruses creates hybrid viruses with substantial virulence. Proc Natl Acad Sci U S A, 107: 4687–4692.PubMedCrossRefGoogle Scholar
  63. Li K S, Guan Y and Wang J. 2004. Genesis of a highly pathogenic and potentially pandemic H5N1 Influenza virus in eastern Asia. Nature, 430: 209–213.PubMedCrossRefGoogle Scholar
  64. Li W, Wang G, Zhang H, Xin G, Zhang D, Zeng J, Chen X, Xu Y, Cui Y and Li K. 2010. Effects of NS1 variants of H5N1 influenza virus on interferon induction, TNFalpha response and p53 activity. Cell Mol Immunol, 7: 235–242.PubMedCrossRefGoogle Scholar
  65. Li W, Sun W, Liu L, Yang F, Li Y, Chen Y, Fang J, Zhang W, Wu J and Zhu Y. 2010. IL-32: a host proinflammatory factor against influenza viral replication is upregulated by aberrant epigenetic modifications during influenza A virus infection. J Immunol, 185: 5056–5065.PubMedCrossRefGoogle Scholar
  66. Li W, Yang F, Liu Y, Gong R, Liu L, Feng Y, Hu P, Sun W, Hao Q, Kang L, Wu J and Zhu Y. 2009. Negative feedback regulation of IL-32 production by iNOS activation in response to dsRNA or influenza virus infection. Eur J Immunol, 39: 1019–1024.PubMedCrossRefGoogle Scholar
  67. Li W, Liu Y, Mukhtar M M, Gong R, Pan Y, Rasool S T, Gao Y, Kang L, Hao Q, Peng G, Chen Y, Chen X, Wu J and Zhu Y. 2008. Activation of interleukin-32 pro-inflammatory pathway in response to influenza A virus infection. PLoS One, 3: e1985.PubMedCrossRefGoogle Scholar
  68. Lipatov A S Andreansky S, Webby R J, Hulse D J, Rehg J E, Krauss S, Perez D R, Doherty P C, Webster R G and Sangster M Y. 2005. Pathogenesis of Hong Kong H5N1 influenza virus NS gene reassortants in mice: the role of cytokines and B- and T-cell responses. J Gen Virol, 86: 1121–1130.PubMedCrossRefGoogle Scholar
  69. Liu J, Xiao H, Lei F, Zhu Q, Qin K, Zhang X W, Zhang X L, Zhao D, Wang G, Feng Y, Ma J, Liu W, Wang J and Gao G F. 2005. Highly pathogenic H5N1 influenza virus infection in migratory birds. Science, 309: 1206.PubMedCrossRefGoogle Scholar
  70. Liu L, Cao Z, Chen J, Li R, Cao Y, Zhu C, Wu K, Wu J, Liu F and Zhu Y. 2012. Influenza A virus induces interleukin-27 through cyclooxygenase-2 and protein kinase A signaling. J Biol Chem, 287: 11899–11910.PubMedCrossRefGoogle Scholar
  71. Loeffelholz M J. 2010. Avian influenza A H5N1 virus. Clin Lab Med, 30: 1–20.PubMedCrossRefGoogle Scholar
  72. Loeffelholz M J. 2011. Avian Influenza (H5N1) Update: Role of the Clinical Microbiology Laboratory. Labmedicine, 42: 291–298.Google Scholar
  73. Long J X, Peng D X, Liu Y L, Wu Y T and Liu X F. 2008. Virulence of H5N1 avian influenza virus enhanced by a 15-nucleotide deletion in the viral nonstructural gene. Virus Genes, 36: 471–478.PubMedCrossRefGoogle Scholar
  74. Lowen A C, Mubareka S, Steel J and Palese P. 2007. Influenza virus transmission is dependent on relative humidity and temperature. PLoS Pathog, 3: 1470–1476.PubMedCrossRefGoogle Scholar
  75. Luke J M, Simon G G, Soderholm J, Errett J S, August J T, Gale M, Jr., Hodgson C P and Williams J A. 2011. Coexpressed RIG-I agonist enhances humoral immune response to influenza virus DNA vaccine. J Virol, 85: 1370–1383.PubMedCrossRefGoogle Scholar
  76. Malaisree M, Rungrotmongkol T, Nunthaboot N, Aruksakunwong O, Intharathep P, Decha P, Sompornpisut P and Hannongbua S. 2009. Source of oseltamivir resistance in avian influenza H5N1 virus with the H274Y mutation. Amino Acids, 37: 725–732.PubMedCrossRefGoogle Scholar
  77. Manz B, Matrosovich M, Bovin N and Schwemmle M. 2010. A polymorphism in the hemagglutinin of the human isolate of a highly pathogenic H5N1 influenza virus determines organ tropism in mice. J Virol, 84: 8316–8321.PubMedCrossRefGoogle Scholar
  78. Medina R A and Garcia-Sastre A. 2011. Influenza A viruses: new research developments. Nat Rev Microbiol, 9: 590–603.PubMedCrossRefGoogle Scholar
  79. Mok C K, Lee D C, Cheung C Y, Peiris M and Lau A S. 2007. Differential onset of apoptosis in influenza A virus H5N1- and H1N1-infected human blood macrophages. J Gen Virol, 88: 1275–1280.PubMedCrossRefGoogle Scholar
  80. Mukhtar M M, Rasool S T, Song D, Zhu C, Hao Q, Zhu Y and Wu J. 2007. Origin of highly pathogenic H5N1 avian influenza virus in China and genetic characterization of donor and recipient viruses. J Gen Virol, 88: 3094–3099.PubMedCrossRefGoogle Scholar
  81. Munir M, Zohari S, Metreveli G, Baule C, Belak S and Berg M. 2011. Alleles A and B of non-structural protein 1 of avian influenza A viruses differentially inhibit beta interferon production in human and mink lung cells. J Gen Virol, 92: 2111–2121.PubMedCrossRefGoogle Scholar
  82. Nduati R, Richardson B A, John G, Mbori-Ngacha D, Mwatha A, Ndinya-Achola J, Bwayo J, Onyango F E and Kreiss J. 2001. Effect of breastfeeding on mortality among HIV-1 infected women: a randomised trial. Lancet, 357: 1651–1655.PubMedCrossRefGoogle Scholar
  83. Ndung’u T, Sepako E, McLane M F, Chand F, Bedi K, Gaseitsiwe S, Doualla-Bell F, Peter T, Thior I, Moyo S M, Gilbert P B, Novitsky V A and Essex M. 2006. HIV-1 subtype C in vitro growth and coreceptor utilization. Virology, 347: 247–260.PubMedCrossRefGoogle Scholar
  84. Nelson M I and Holmes E C. 2007. The evolution of epidemic influenza. Nat Rev Genet, 8: 196–205.PubMedCrossRefGoogle Scholar
  85. Nicholls J M, Bourne A J, Chen H, Guan Y and Peiris J S. 2007. Sialic acid receptor detection in the human respiratory tract: evidence for widespread distribution of potential binding sites for human and avian influenza viruses. Respir Res, 8: 73.PubMedCrossRefGoogle Scholar
  86. Nicholls J M, Chan M C, Chan W Y, Wong H K, Cheung C Y, Kwong D L, Wong M P, Chui W H, Poon L L, Tsao S W, Guan Y and Peiris J S. 2007. Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat Med, 13: 147–149.PubMedCrossRefGoogle Scholar
  87. Noah D L, Hill H, Hines D, White E L and Wolff M C. 2009. Qualification of the hemagglutination inhibition assay in support of pandemic influenza vaccine licensure. Clin Vaccine Immunol, 16: 558–566.PubMedCrossRefGoogle Scholar
  88. Noda T, Sagara H, Yen A, Takada A, Kida H, Cheng R H and Kawaoka Y. 2006. Architecture of ribonucleoprotein complexes in influenza A virus particles. Nature, 439: 490–492.PubMedCrossRefGoogle Scholar
  89. Nolan T, Richmond P C, Formica N T, Hoschler K, Skeljo M V, Stoney T, McVernon J, Hartel G, Sawlwin D C, Bennet J, Ryan D, Basser R L and Zambon M C. 2008. Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children. Vaccine, 26: 6383–6391.PubMedCrossRefGoogle Scholar
  90. Ohnishi K, Takahashi Y, Kono N, Nakajima N, Mizukoshi F, Misawa S, Yamamoto T, Mitsuki Y Y, Fu S, Hirayama N, Ohshima M, Ato M, Kageyama T, Odagiri T, Tashiro M, Kobayashi K, Itamura S and Tsunetsugu-Yokota Y. 2012. Newly established monoclonal antibodies for immunological detection of H5N1 influenza virus. Jpn J Infect Dis, 65: 19–27.PubMedCrossRefGoogle Scholar
  91. Park A W and Glass K. 2007. Dynamic patterns of avian and human influenza in east and southeast Asia. Lancet Infect Dis, 7: 543–548.PubMedCrossRefGoogle Scholar
  92. Peiris J S, de Jong M D and Guan Y. 2007. Avian influenza virus (H5N1): a threat to human health. Clin Microbiol Rev, 20: 243–267.PubMedCrossRefGoogle Scholar
  93. Peiris J S, Hui K P and Yen H L. 2010. Host response to influenza virus: protection versus immunopathology. Curr Opin Immunol, 22: 475–481.PubMedCrossRefGoogle Scholar
  94. Peiris J S, Cheung C Y, Leung C Y and Nicholls J M. 2009. Innate immune responses to influenza A H5N1: friend or foe? Trends Immunol, 30: 574–584.PubMedCrossRefGoogle Scholar
  95. Peiris M. 2006. Pathogenesis of avian flu H5N1 and SARS. Novartis Found Symp, 279: 56–60; discussion 60–55, 216–219.PubMedCrossRefGoogle Scholar
  96. Pfeiffer D U, Otte M J, Roland-Holst D, Inui K, Nguyen T and Zilberman D. 2011. Implications of global and regional patterns of highly pathogenic avian influenza virus H5N1 clades for risk management. Vet J, 190: 309–316.PubMedCrossRefGoogle Scholar
  97. Qin G, Mao H, Zheng J, Sia S F, Liu Y, Chan P L, Lam K T, Peiris J S, Lau Y L and Tu W. 2009. Phosphoantigen-expanded human gammadelta T cells display potent cytotoxicity against monocyte-derived macrophages infected with human and avian influenza viruses. J Infect Dis, 200: 858–865.PubMedCrossRefGoogle Scholar
  98. Qin G, Liu Y, Zheng J, Ng I H, Xiang Z, Lam K T, Mao H, Li H, Peiris J S, Lau Y L and Tu W. 2011. Type 1 responses of human Vgamma9Vdelta2 T cells to influenza A viruses. J Virol, 85: 10109–10116.PubMedCrossRefGoogle Scholar
  99. Ramos I, Bernal-Rubio D, Durham N, Belicha-Villanueva A, Lowen A C, Steel J and Fernandez-Sesma A. 2011. Effects of receptor binding specificity of avian influenza virus on the human innate immune response. J Virol, 85: 4421–4431.PubMedCrossRefGoogle Scholar
  100. Reperant L A, van de Bildt M W, van Amerongen G, Buehler D M, Osterhaus A D, Jenni-Eiermann S, Piersma T and Kuiken T. 2011. Highly pathogenic avian influenza virus H5N1 infection in a long-distance migrant shorebird under migratory and non-migratory states. PLoS One, 6: e27814.PubMedCrossRefGoogle Scholar
  101. Rimmelzwaan G F, Kuiken T, van Amerongen G, Bestebroer T M, Fouchier R A and Osterhaus A D. 2001. Pathogenesis of influenza A (H5N1) virus infection in a primate model. J Virol, 75: 6687–6691.PubMedCrossRefGoogle Scholar
  102. Robb N C and Fodor E. 2012. The accumulation of influenza A virus segment 7 spliced mRNAs is regulated by the NS1 protein. J Gen Virol, 93: 113–118.PubMedCrossRefGoogle Scholar
  103. Rockman S and Brown L. 2010. Pre-pandemic and pandemic influenza vaccines. Hum Vaccin, 6: 792–801.PubMedCrossRefGoogle Scholar
  104. Sambhara S and Poland G A. 2010. H5N1 Avian influenza: preventive and therapeutic strategies against a pandemic. Annu Rev Med, 61: 187–198.PubMedCrossRefGoogle Scholar
  105. Sandbulte M R, Boon A C, Webby R J and Riberdy J M. 2008. Analysis of cytokine secretion from human plasmacytoid dendritic cells infected with H5N1 or low-pathogenicity influenza viruses. Virology, 381: 22–28.PubMedCrossRefGoogle Scholar
  106. Seo S H, Hoffmann E and Webster R G. 2002. Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat Med, 8: 950–954.PubMedCrossRefGoogle Scholar
  107. Shaw M, Arden N H and Maassab H F. 1992. New Aspect of Influenza Viruses. Clin Microbiol Rev, 5: 74–92.PubMedGoogle Scholar
  108. Shu Y, Yu H and Li D. 2006. Lethal avian influenza A (H5N1) infection in a pregnant woman in Anhui Province, China. N Engl J Med, 354: 1421–1422.PubMedCrossRefGoogle Scholar
  109. Snelgrove R J, Godlee A and Hussell T. 2011. Airway immune homeostasis and implications for influenza-induced inflammation. Trends Immunol, 32: 328–334.PubMedCrossRefGoogle Scholar
  110. Stelzer-Braid S, Wong B, Robertson P, Lynch G W, Laurie K, Shaw R, Barr I, Selleck P W, Baleriola C, Escott R, Katsoulotos G and Rawlinson W D. 2008. A commercial ELISA detects high levels of human H5 antibody but cross-reacts with influenza A antibodies. J Clin Virol, 43: 241–243.PubMedCrossRefGoogle Scholar
  111. Stevens J, Blixt O, Tumpey T M, Taubenberger J K, Paulson J C and Wilson I A. 2006. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science, 312: 404–410.PubMedCrossRefGoogle Scholar
  112. Stewart C R, Karpala A J, Lowther S, Lowenthal J W and Bean A G. 2011. Immunostimulatory motifs enhance antiviral siRNAs targeting highly pathogenic avian influenza H5N1. PLoS One, 6: 7.Google Scholar
  113. Suarez D L. 2010. Avian influenza: our current understanding. Anim Health Res Rev, 11: 19–33.PubMedCrossRefGoogle Scholar
  114. Suarez D L and Schultz-Cherry S. 2000. Immunology of avian influenza virus: a review. Dev Comp Immunol, 24: 269–283.PubMedCrossRefGoogle Scholar
  115. Subbarao E K, London W and Murphy B R. 1993. A single amino acid in the PB2 gene of influenza A virus is a determinant of host range. J Virol, 67: 1761–1764.PubMedGoogle Scholar
  116. Subbarao K, Klimov A, Katz J, Regnery H, Lim W, Hall H, Perdue M, Swayne D, Bender C, Huang J, Hemphill M, Rowe T, Shaw M, Xu X, Fukuda K and Cox N. 1998. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science, 279: 393–396.PubMedCrossRefGoogle Scholar
  117. Suksatu A, Sangsawad W, Thitithanyanont A, Smittipat N, Fukuda M M and Ubol S. 2009. Characteristics of stork feces-derived H5N1 viruses that are preferentially transmitted to primary human airway epithelial cells. Microbiol Immunol, 53: 675–684.PubMedCrossRefGoogle Scholar
  118. Sun Y, Li C, Shu Y, Ju X, Zou Z, Wang H, Rao S, Guo F, Liu H, Nan W, Zhao Y, Yan Y, Tang J, Zhao C, Yang P, Liu K, Wang S, Lu H, Li X, Tan L, Gao R, Song J, Gao X, Tian X, Qin Y, Xu K F, Li D, Jin N and Jiang C. 2012. Inhibition of autophagy ameliorates acute lung injury caused by avian influenza A H5N1 infection. Sci Signal, 5: ra16.PubMedCrossRefGoogle Scholar
  119. Szretter K J, Gangappa S, Lu X, Smith C, Shieh W J, Zaki S R, Sambhara S, Tumpey T M and Katz J M. 2007. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J Virol, 81: 2736–2744.PubMedCrossRefGoogle Scholar
  120. Szretter K J, Gangappa S, Belser J A, Zeng H, Chen H, Matsuoka Y, Sambhara S, Swayne D E, Tumpey T M and Katz J M. 2009. Early control of H5N1 influenza virus replication by the type I interferon response in mice. J Virol, 83: 5825–5834.PubMedCrossRefGoogle Scholar
  121. Tafforeau L, Chantier T, Pradezynski F, Pellet J, Mangeot P E, Vidalain P O, Andre P, Rabourdin-Combe C and Lotteau V. 2011. Generation and comprehensive analysis of an influenza virus polymerase cellular interaction network. J Virol, 85: 13010–13018.PubMedCrossRefGoogle Scholar
  122. Thanh T T, van Doorn H R and de Jong M D. 2008. Human H5N1 influenza: current insight into pathogenesis. Int J Biochem Cell Biol, 40: 2671–2674.PubMedCrossRefGoogle Scholar
  123. Thiry E, Zicola A, Addie D, Egberink H, Hartmann K, Lutz H, Poulet H and Horzinek M C. 2007. Highly pathogenic avian influenza H5N1 virus in cats and other carnivores. Vet Microbiol, 122: 25–31.PubMedCrossRefGoogle Scholar
  124. Tolnay A E, Baskin C R, Tumpey T M, Sabourin P J, Sabourin C L, Long J P, Pyles J A, Albrecht R A, Garcia-Sastre A, Katze M G and Bielefeldt-Ohmann H. 2010. Extrapulmonary tissue responses in cynomolgus macaques (Macaca fascicularis) infected with highly pathogenic avian influenza A (H5N1) virus. Arch Virol, 155: 905–914.PubMedCrossRefGoogle Scholar
  125. Tu W, Zheng J, Liu Y, Sia S F, Liu M, Qin G, Ng I H, Xiang Z, Lam K T, Peiris J S and Lau Y L. 2011. The aminobisphosphonate pamidronate controls influenza pathogenesis by expanding a gammadelta T cell population in humanized mice. J Exp Med, 208: 1511–1522.PubMedCrossRefGoogle Scholar
  126. Ungchusak K, Auewarakul P, Dowell S F, Kitphati R, Auwanit W, Puthavathana P, Uiprasertkul M, Boonnak K, Pittayawonganon C, Cox N J, Zaki S R, Thawatsupha P, Chittaganpitch M, Khontong R, Simmerman J M and Chunsutthiwat S. 2005. Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med, 352: 333–340.PubMedCrossRefGoogle Scholar
  127. Van Kerkhove M D, Mumford E, Mounts A W, Bresee J, Ly S, Bridges C B and Otte J. 2011. Highly pathogenic avian influenza (H5N1): pathways of exposure at the animal-human interface, a systematic review. PLoS One, 6: e14582.PubMedCrossRefGoogle Scholar
  128. van Riel D, Munster V J, de Wit E, Rimmelzwaan G F, Fouchier R A, Osterhaus A D and Kuiken T. 2006. H5N1 Virus Attachment to Lower Respiratory Tract. Science, 312: 399.PubMedCrossRefGoogle Scholar
  129. van Riel D, Munster V J, de Wit E, Rimmelzwaan G F, Fouchier R A, Osterhaus A D and Kuiken T. 2007. Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am J Pathol, 171: 1215–1223.PubMedCrossRefGoogle Scholar
  130. Vandegrift K J, Sokolow S H, Daszak P and Kilpatrick A M. 2010. Ecology of avian influenza viruses in a changing world. Ann N Y Acad Sci, 1195: 113–128.PubMedCrossRefGoogle Scholar
  131. Wan H and Perez D R. 2006. Quail carry sialic acid receptors compatible with binding of avian and human influenza viruses. Virology, 346: 278–286.PubMedCrossRefGoogle Scholar
  132. Wang H and Jiang C. 2009. Avian influenza H5N1 an update on molecular pathogensis. Sci China C Life Sci, 52: 459–463.PubMedCrossRefGoogle Scholar
  133. Wang J, Oberley-Deegan R, Wang S, Nikrad M, Funk C J, Hartshorn K L and Mason R J. 2009. Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-lambda 1) in response to influenza A infection. J Immunol, 182: 1296–1304.PubMedGoogle Scholar
  134. Wang S, Hackett A, Jia N, Zhang C, Zhang L, Parker C, Zhou A, Li J, Cao W C, Huang Z, Li Y and Lu S. 2011. Polyvalent DNA vaccines expressing HA antigens of H5N1 influenza viruses with an optimized leader sequence elicit cross-protective antibody responses. PLoS One, 6: e28757.PubMedCrossRefGoogle Scholar
  135. Wasilenko J L, Lee C W, Sarmento L, Spackman E, Kapczynski D R, Suarez D L and Pantin-Jackwood M J. 2008. NP, PB1 and PB2 viral genes contribute to altered replication of H5N1 avian influenza viruses in chickens. J Virol, 82: 4544–4553.PubMedCrossRefGoogle Scholar
  136. Watanabe Y, Ibrahim M S, Suzuki Y and Ikuta K. 2012. The changing nature of avian influenza A virus (H5N1). Trends Microbiol, 20: 11–20.PubMedCrossRefGoogle Scholar
  137. Webster R G, Bean W J, Gorman O T, Chambers T M and Kawaoka Y. 1992. Evolution and ecology of influenza A viruses. Microbiol Rev, 56: 152–179.PubMedGoogle Scholar
  138. Wise H M, Foeglein A, Sun J, Dalton R M, Patel S, Howard W, Anderson E C, Barclay W S and Digard P. 2009. A complicated message: Identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. J Virol, 83: 8021–8031.PubMedCrossRefGoogle Scholar
  139. Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A (H5N1) V. 2008. Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med, 358: 261–273.CrossRefGoogle Scholar
  140. Yu W C, Chan R W, Wang J, Travanty E A, Nicholls J M, Peiris J S, Mason R J and Chan M C. 2011. Viral replication and innate host responses in primary human alveolar epithelial cells and alveolar macrophages infected with influenza H5N1 and H1N1 viruses. J Virol, 85: 6844–6855.PubMedCrossRefGoogle Scholar
  141. Yuen K Y, Chan P K, Peiris M, Tsang D N, Que T L, Shortridge K F, Cheung P T, To W K, Ho E T, Sung R and Cheng A F. 1998. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet, 351: 467–471.PubMedCrossRefGoogle Scholar
  142. Zamarin D, Ortigoza M B and Palese P. 2006. Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J Virol, 80: 7976–7983.PubMedCrossRefGoogle Scholar
  143. Zamarin D, Garcia-Sastre A, Xiao X, Wang R and Palese P. 2005. Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog, 1: e4.PubMedCrossRefGoogle Scholar
  144. Zeng H, Goldsmith C, Thawatsupha P, Chittaganpitch M, Waicharoen S, Zaki S, Tumpey T M and Katz J M. 2007. Highly pathogenic avian influenza H5N1 viruses elicit an attenuated type i interferon response in polarized human bronchial epithelial cells. J Virol, 81: 12439–12449.PubMedCrossRefGoogle Scholar
  145. Zheng B J, Chan K W, Lin Y P, Zhao G Y, Chan C, Zhang H J, Chen H L, Wong S S, Lau S K, Woo P C, Chan K H, Jin D Y and Yuen K Y. 2008. Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus. Proc Natl Acad Sci U S A, 105: 8091–8096.PubMedCrossRefGoogle Scholar
  146. Zhu Q, Yang H, Chen W, Cao W, Zhong G, Jiao P, Deng G, Yu K, Yang C, Bu Z, Kawaoka Y and Chen H. 2008. A naturally occurring deletion in its NS gene contributes to the attenuation of an H5N1 swine influenza virus in chickens. J Virol, 82: 220–228.PubMedCrossRefGoogle Scholar

Copyright information

© Wuhan Institute of Virology, CAS and Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  1. 1.The State Key laboratory of Virology and College of Life SciencesWuhan UniversityWuhanChina

Personalised recommendations